NYT turns gaze on measles outbreak; GSK faces chickenpox vax shortage;

> The New York Times editorial board has turned its gaze to the British measles outbreak. Item

> A court has allowed a woman who had a vaccine damages case dismissed to seek lawyer's fees. News

> Intercell ($ICLL) has won FDA approval for a pediatric indication of its Japanese encephalitis vaccine. Release (pdf)

> A Singapore-made H1N1 vaccine has entered Phase I clinical trials. Article

> Surging demand for GlaxoSmithKline's ($GSK) chickenpox vaccine in New Zealand has created a shortage. News

Suggested Articles

GSK's Shingrix has generated blockbuster sales early in the launch, but there's a lot of remaining opportunity, an exec said at JPM.

Quickly after Merck's world-first Ebola vaccine approval in Europe, U.S. authorities licensed the shot.

In an effort to stop an Ebola outbreak that has claimed 2,200 lives at the Rwanda border, J&J is shipping 200,000 doses of its vaccine to the country.